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Infection, vaccination, and childhood
arterial ischemic stroke
Results of the VIPS study
ABSTRACT
Objectives: Minor infection can trigger adult arterial ischemic stroke (AIS) and is common in child-
hood.We tested the hypotheses that infection transiently increases risk of AIS in children, regard-
less of stroke subtype, while vaccination against infection is protective.
Methods: The Vascular Effects of Infection in Pediatric Stroke study is an international case-
control study that prospectively enrolled 355 centrally confirmed cases of AIS (29 days–18
years old) and 354 stroke-free controls. To determine prior exposure to infections and vaccines,
we conducted parental interviews and chart review.
Results: Median (interquartile range) age was 7.6 years for cases and 9.3 for controls (p 5 0.44).
Infection in the week prior to stroke, or interview date for controls, was reported in 18% of cases,
vs 3% of controls, conferring a 6.3-fold increased risk of AIS (p , 0.0001); upper respiratory
infections were most common. Prevalence of preceding infection was similar across stroke sub-
types: arteriopathic, cardioembolic, and idiopathic. Use of vasoactive cold medications was sim-
ilarly low in both groups. Children with some/few/no routine vaccinations were at higher stroke
risk than those receiving all or most (odds ratio [OR] 7.3, p 5 0.0002). In an age-adjusted mul-
tivariate logistic regression model, independent risk factors for AIS included infection in the prior
week (OR 6.3, p , 0.0001), undervaccination (OR 8.2, p 5 0.0004), black race (compared to
white; OR 1.9, p 5 0.009), and rural residence (compared to urban; OR 3.0, p 5 0.0003).
Conclusions: Infection may act as a trigger for childhood AIS, while routine vaccinations appear
protective. Hence, efforts to reduce the spread of common infections might help prevent stroke
in children. Neurology® 2015;85:1459–1466
GLOSSARY
AIS 5 arterial ischemic stroke; CI 5 confidence interval; IQR 5 interquartile range; OR 5 odds ratio; PFO 5 patent foramen
ovale; SES 5 socioeconomic status; VIPS 5 Vascular Effects of Infection in Pediatric Stroke.
Ischemic stroke affects at least 2.4 per 100,000 US children every year.1,2 Historical impressions
that children recover well from stroke have been contradicted by outcome studies that document
a high rate of lifelong morbidity.3–5 A better understanding of the causes of childhood stroke is
needed to develop strategies for prevention.
Major infections—bacterial meningitis, sepsis, endocarditis—have long been associated with
arterial ischemic stroke (AIS) in children. Minor infections occur more frequently, and have
been linked to AIS risk in adults.6–14 In a retrospective case-control study set in Northern
California, we found that a medical encounter for minor infection transiently increased AIS
risk 15-fold (p , 0.0001) over a 3-day period, and that this risk factor was present in 10% of
childhood AIS cases.15 This suggests a potential opportunity for primary stroke prevention
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through improved hygiene and vaccination,
and potential avenues for secondary stroke
prevention by expanding our understanding
of stroke pathogenesis in children. The study
was limited by its narrow geographic region,
retrospective data, inability to measure infec-
tions not resulting in a medical encounter (or
exposure to vasoactive cold medications),
and poor characterization of stroke subtypes
because imaging studies were not available
for review.
We sought to further assess the association
between infection and AIS, and test the
hypothesis that vaccinations are protective, in
a large, international case-control study of
childhood AIS: the Vascular Effects of Infec-
tion in Pediatric Stroke (VIPS) study. We also
sought to determine whether the association
with infection varies by subtype: arteriopathic,
cardioembolic, or idiopathic.
METHODS Setting and case enrollment. Between January
2010 and March 2014, VIPS prospectively enrolled cases of
childhood AIS, and stroke-free controls, at 37 International
Pediatric Stroke Study centers in 9 countries. Our target
sample size (350 cases and 350 controls) was chosen to have
.80% power to detect an association between recent infection
and childhood AIS subtypes, with a set at 0.05. Ethics approvals
were obtained at each site. Details of case ascertainment,
confirmation, imaging review, laboratory analyses, and clinical
data collection are published.16,17 Case inclusion criteria were
age 29 days through 18 years at the time of AIS, brain MRI
including cerebrovascular imaging, enrollment within 3 weeks
of stroke ictus (a change from 2 weeks in the published
methods), and consent/assent to study participation including
blood collection. Local research staff abstracted data from
medical records, interviewed parents/guardians, and mailed
neuroimaging studies on CD to the imaging core at the
University of California San Francisco.
Case confirmation and classification of stroke subtype.
Cases were confirmed centrally by 2 investigators, with adjudica-
tion by a third, using pre-established clinical and imaging criteria
for AIS.16 All cases were subjected to a rigorous process for
classifying the presence and type of an arteriopathy.17 Cases
with no arteriopathy were further classified as cardioembolic if
there was a history of congenital or acquired heart disease,
excluding isolated patent foramen ovale (PFO); presumed
embolic with prothrombotic condition if the child had an
acquired (e.g., sepsis) or genetic prothrombotic condition; other
etiology if there was another established stroke cause or risk
factor; and idiopathic if no stroke risk factors were identified.
Children with only PFO or migraine were considered
idiopathic. Cardioembolic strokes were further classified as
procedure-related, if coincident with a cardiac procedure, or
spontaneous.
Control enrollment. VIPS enrolled stroke-free controls aged
29 days through 18 years. Controls were selected to minimize
bias either towards or against having a recent infection. There
Table 1 Characteristics of patients with childhood arterial ischemic stroke and
age-matched controls, based on parental interview
Characteristics
Cases
(n 5 355), n (%)
Controls
(n 5 354), n (%) p Value
Demographics
Age, y, median (IQR) 7.6 (2.8–14.3) 9.3 (4.4–13.3) 0.44
Male 199 (56.1) 195 (55.1) 0.34
Race 0.24
White 230 (64.8) 223 (63.0)
Black 39 (11.0) 26 (7.3)
East Asian 9 (2.5) 4 (1.1)
Indian/South Asian 26 (7.3) 23 (6.5)
Middle Eastern 3 (0.8) 4 (1.1)
First Nations/Aboriginal 4 (1.1) 4 (1.1)
Pacific Islander 1 (0.3) 2 (0.6)
Mixed or other 38 (10.7) 62 (17.5)
Unknown 5 (1.4) 6 (1.7)
Ethnicity 0.17
Non-Hispanic 289 (81.4) 276 (78.0)
Hispanic 47 (13.2) 45 (12.7)
Mixed or other 19 (5.4) 33 (9.3)
Country 0.001a
United States 223 (62.8) 188 (53.1)
Canada 60 (16.9) 121 (34.2)
Australia 16 (4.5) 3 (0.8)
Philippines 16 (4.5) 12 (3.4)
Chile 14 (3.9) 13 (3.7)
United Kingdom 11 (3.1) 6 (1.7)
France 6 (1.7) 3 (0.8)
Serbia 5 (1.4) 4 (1.1)
China 4 (1.1) 4 (1.1)
Socioeconomic status
Residence ,0.0001a
Urban 118 (33.2) 184 (52.0)
Suburban 153 (43.1) 126 (35.6)
Rural 82 (23.1) 44 (12.4)
Household income (in US dollars) 0.001a
<$10,000 55 (15.5) 30 (8.5)
$10,000–30,000 68 (19.2) 66 (18.6)
$31,000–50,000 47 (13.2) 53 (15.0)
$50,000–100,000 90 (25.4) 83 (23.4)
>100,000 64 (18.0) 105 (29.7)
Missing 31 (8.7) 17 (4.8)
Maternal education, highest level ,0.0001a
Less than high school 43 (12.1) 16 (4.5)
High school graduate 83 (23.4) 58 (16.4)
Some college education 109 (30.7) 110 (31.1)
Continued
1460 Neurology 85 October 27, 2015
ª 2015 American Academy of Neurology. Unauthorized reproduction of this article is prohibited.
were 2 types of controls: routine visit controls enrolled at the time
of a routinely scheduled clinic visit to a primary provider for an
annual checkup or a neurologist for headache or developmental
delay (target n 5 230) and trauma visit controls enrolled at the
time of an urgent visit or admission for trauma (target n 5 120).
Children attending a routine visit would be biased against a major
infection requiring hospitalization; however, those with minor
infections would likely still attend a scheduled medical
appointment. The trauma controls were included because they
could provide a research blood sample (at the time of clinical
phlebotomy or IV insertion), and would be relatively unbiased
with regards to infection except that very ill children might be less
active, and hence less likely to experience trauma. (Most other
children undergoing clinical venous access could be biased either
towards infection, if the reason for phlebotomy is directly or
indirectly related to infection, or against, if undergoing an
elective procedure.) The laboratory assays will be the subject of
future analyses. Sites that did not have a pediatric trauma center
could not feasibly enroll trauma controls. Although controls were
not pairwise matched, sites were asked to enroll roughly the same
number of cases as controls. In addition, age histograms and
geographic maps of cases and controls were provided to the
sites throughout the enrollment period to encourage a similar
demographic distribution.
Parental interview. Parents/guardians participated in a struc-
tured interview (appendix e-1 on the Neurology® Web site at
Neurology.org) performed as soon as possible (maximum of
1 week after enrollment, or 3 weeks after stroke, whichever
came first). The interview included questions about infections
and vaccinations prior to the stroke ictus (for cases), the trauma
event (for trauma visit controls), or enrollment (for routine visit
controls). Because recommended vaccines vary by age and
country, we asked, as a general indicator of vaccine status,
whether the child had received all, most, some, few, or none of
the routine vaccines expected for his or her age, and classified
children as poorly vaccinated if the parent responded some/few/
none. We asked about conditions that we did not expect to be
associated with AIS (umbilical hernia and abnormal head shape
during infancy) as a measure of recall bias. Exposure to vasoactive
medications was assessed using lists of medications and locally
available brand name cold remedies known to contain them.
Diphenhydramine, a common nonvasoactive ingredient in cold
remedies, was included to gauge recall bias.
Major infection. Major infection included diagnoses of menin-
gitis/encephalitis and bacteremia/sepsis, as previously defined.16
These diagnoses were ascertained through chart review, and
included diagnoses made after the stroke as long as the infection
was thought to precede the stroke. All other infections were mea-
sured by the parental interview.
Data analysis. Interview questions that parents answered as
unknown were counted as missing values. Unadjusted compari-
sons between cases and controls were made using x2 and Fisher
exact tests for categorical variables and the Wilcoxon rank sum
test for continuous variables.
We used logistic regression models to identify factors associ-
ated with childhood AIS. In all models, we adjusted for age (as a
categorical variable given its nonlinear relationship with AIS) to
account for age-related variability in rates of exposure to infection
and vaccinations, and for country income level, which would
likely influence vaccination rates. For this purpose, countries were
categorized as either lower and middle income countries (Philip-
pines, Serbia, and China) or high-income countries (all others), as
defined by the World Bank in 2014 (http://data.worldbank.org/
country; accessed November 25, 2014). In our final multivariable
models, we also adjusted for race, because of previously reported
racial differences in childhood stroke risk,18 season (because of
seasonal variation in infection), and socioeconomic status (SES).
Our markers of SES (urban/suburban/rural residence, household
income, and highest level of maternal education) were highly
correlated with one another; we alternated these indicators in
multivariable models and compared results. Our primary analyses
included children with major infections. To account for the fact
that controls would be less likely to have been diagnosed with a
major infection, we conducted sensitivity analyses excluding cases
with major infection. To address potential selection bias related to
our trauma visit controls (as a current infection could reduce risk
of trauma), we conducted additional sensitivity analyses compar-
ing cases to each control group separately. We used Stata v12
(Stata Corporation, College Station, TX) for all analyses.
RESULTS VIPS sites screened 650 potential cases,
and enrolled 387 (160 did not meet inclusion criteria,
64 did not consent, and 39 had an inadequate blood
sample); 32 were excluded upon central review. The
study included 355 confirmed cases and 354 controls
(234 routine visit and 120 trauma visit). Parental in-
terviews were performed at a median (interquartile
range [IQR]) of 1 (0–3) day after case enrollment
(6 [4–11] days after stroke) and 0 (0–0) days after
control enrollment. The trauma visit controls were
similar to routine visit controls except more likely
to be older, male, Canadian, and residing in a rural
area (table e-1). Demographics were similar between
cases and controls, except for country of enrollment
and SES (table 1). Although case and control age was
similar when the controls were combined, the trauma
visit controls were older (figure). Cases were similar to
controls in frequency of doctor’s appointments and
parental report of umbilical hernia or abnormal head
shape.
Stroke subtype, comorbidities and risk factors,
presentation, and infarct characteristics have been
published.17 Of the 355 cases, 127 (36%) had a
Table 1 Continued
Characteristics
Cases
(n 5 355), n (%)
Controls
(n 5 354), n (%) p Value
Bachelor’s degree, or equivalent 68 (19.2) 89 (25.1)
Some graduate education 8 (2.3) 15 (4.2)
Graduate degree 30 (8.5) 61 (17.2)
Missing 14 (3.9) 5 (1.4)
No. of routine visits to a doctor’s office, past
24 months, median (IQR)b
2 (2–4) 2 (2–4) 0.06
Variables included in interview to detect
recall bias
Umbilical hernia during infancy 15 (4.2) 12 (3.4) 0.56
Abnormal head shape during infancy 16 (4.5) 11 (3.1) 0.43
Abbreviation: IQR 5 interquartile range.
a Significant.
bRange 0 to 36 visits for cases, 0 to 60 for controls.
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definite arteriopathy, 34 (10%) a possible arteriopa-
thy, and 194 (55%) no arteriopathy, including 76
(21%) cardioembolic (65 spontaneous and 11
procedure-related), 9 (3%) presumed embolic with
a prothrombotic condition, 19 (5%) with another
etiology (genetic syndrome, n 5 10; meningitis/
encephalitis, head trauma, and cancer, each n 5 3),
and 90 (25%) idiopathic.
Exposures based on parental interview are shown
in table 2. Adjusted only for age, cases were more
likely than controls to have a reported infection in
the prior week (odds ratio [OR] 6.3, 95% confidence
interval [CI] 3.3–12, p , 0.0001), prior month (OR
2.3, 95% CI 1.6–3.2, p , 0.0001), and prior 6
months (OR 1.3, 95% CI 0.97–1.8, p5 0.08). After
also adjusting for infection in the prior week, neither
infection in the prior month (OR 1.4, 95% CI 0.92–
2.0, p 5 0.12) nor prior 6 months (OR 1.1, 95% CI
0.80–1.5, p 5 0.53) remained significant. Of the 64
cases reporting recent infections (prior week), 32
(50%) had upper respiratory infections and 33
(52%) had a fever. Few cases or controls reported
exposure to cold medications. In comparing routine
visit to trauma visit controls, there were no differences
in infection in the prior week (table e-1), or in asso-
ciated signs/symptoms, or exposure to cold medica-
tions (data not shown).
Strokes occurred in all months of the year, but
those preceded by infection showed seasonal varia-
tion (figure). Stroke cases with infection in the prior
week had a median age of 4.0 years (IQR 1.5–8.7)
compared to 9.1 (3.5–15) for those without a pre-
ceding infection (p , 0.001), but there were other-
wise no differences between those with or without
infection in demographics or stroke presentation,
location, or size (data not shown). Preceding infec-
tion was common across stroke subtypes, reported in
19 of 127 (15%) with arteriopathic, 14 of 65 (22%)
with spontaneous cardioembolic, and 18 of 90
(20%) with idiopathic AIS (p 5 0.17). It was also
common across subtypes of arteriopathy: 8 of 34
(24%) with moyamoya, 3 of 25 (12%) with transient
cerebral arteriopathy, and 2 of 26 (8%) with arterial
dissection (p 5 0.22).
By parental report, controls were generally better
vaccinated than cases (table 3). Having had a vac-
cination in the prior week (of any type) was associ-
ated with a reduced risk of AIS (OR 0.23, 95% CI
0.10–0.52, p 5 0.0005). Vaccination rates varied
by country income level, but controls were better
vaccinated than cases in each strata (table e-2). Vac-
cination rates were similar between routine visit and
trauma visit controls, with 97% of both groups
receiving all or most routine vaccines expected for
their age (table e-1).
In the multivariable logistic regression model
(table 4), recent infection (prior week) and being
poorly vaccinated remained independent predictors
of childhood AIS, as did lower SES (rural residence
shown, but findings were similar for household
income and maternal education). In a sensitivity
analysis excluding 34 cases with medical record
documentation of major infection (n 5 13 sepsis/
bacteremia, n 5 15 meningitis/encephalitis, n 5 7
both), and using the same variables in the model,
the strength of the association for recent infection
Figure Age and seasonal distributions of childhood arterial ischemic stroke
cases and controls
Histograms demonstrate (A) age distribution of cases of childhood arterial ischemic stroke
(n 5 355), routine visit controls (n 5 234), and trauma visit controls (n 5 120); (B) seasonal
distribution of arterial ischemic strokes in northern hemisphere children, stratified by those
with (n5 63) vs without (n5 262) infection in the prior week; and (C) seasonal distribution of
enrollment of routine visit controls (n5 234) and trauma visit controls (n5 120). (All controls
were enrolled in the northern hemisphere.)
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was similar (OR 6.5, p, 0.0001), while the OR for
being poorly vaccinated lowered from 8.2 to 5.9,
but remained significant (p 5 0.005). In a second
sensitivity analysis, we created models comparing
cases to only routine visit controls, and only trauma
visit controls; CIs widened, but the findings were
similar (table e-3).
DISCUSSION In this prospective, international case-
control study of childhood stroke, infection
transiently increased risk of childhood AIS, regardless
of stroke subtype, while routine vaccinations
appeared protective. These associations persisted even
after adjusting for age, sex, season, and SES. A
preceding infection alone does not fully explain why
AIS occurred in a child; it increases risk only 6-fold
while the baseline population risk is very low. Rather,
infection likely acts as a stroke trigger in a child who
is otherwise predisposed, and explains why the stroke
happened at a particular point in that child’s life.
Major infections have long been considered etiol-
ogies of AIS in both children and adults, while a more
recent body of literature suggests that minor infec-
tions can also act as a trigger for stroke in adults.6–14
Although utilizing different methods to ascertain
infection, a handful of studies have suggested
that minor infection is common prior to AIS in child-
hood. The International Pediatric Stroke Study reg-
istry reported infection as a stroke risk factor in 24%
of 676 AIS cases enrolled in 10 countries, although
infection, including a time frame for exposure, was
not well-defined.19 A single-center UK study reported
“clinical symptoms of infection” in 34% of 212 AIS
cases.20 In the only prior association study, set in the
population of children receiving care from Kaiser Per-
manente Northern California, 33% of 126 cases (vs
13% of controls) had a medical encounter for infec-
tion in the prior 4 weeks,21 and 14% of cases (1.7% of
controls) in the prior 7 days.15 The study reported an
adjusted OR of 15 (95% CI 3.3–68) for minor infec-
tion #3 days prior to stroke, and OR 4.0 (0.9–17.9)
for infection 4–7 days prior.15 This Kaiser study was
geographically narrow, based purely on retrospective
chart review, and unable to review imaging to either
confirm or classify the AIS. VIPS improves upon the
Kaiser study with its large sample size, broad geo-
graphic representation, prospective enrollment, and
central imaging review for case confirmation and
stroke classification. Despite these differences, the
findings were similar. In VIPS, 39% of cases had
parental report of infection in the prior 4 weeks,
and 18% in the prior 1 week. We observed a similar
association between infection and childhood AIS
(adjusted OR 6.5, 95% CI 3.3–13, for infection in
the prior week).
Table 2 Exposures to infection and cold medications among patients with
childhood arterial ischemic stroke and age-matched controls,
measured by parental interview
Characteristics
Cases
(n 5 355), n (%)
Controls
(n 5 354), n (%) p Value
Any infection in the:
Prior week 64 (18.0) 12 (3.4) ,0.0001a
Prior month 137 (38.6) 77 (21.8) ,0.0001a
Prior 6 months 191 (53.8) 164 (46.3) 0.08
Recent infection (prior week)
Type of illness
Cold/upper respiratory infection 32 (9.0) 9 (2.5) 0.0002a
Stomach flu/gastroenteritis 9 (2.5) 0 (0) 0.004a
Ear infection/otitis media 7 (2.0) 1 (0.3) 0.07
Pneumonia 5 (1.4) 0 (0) 0.06
Flu/influenza 3 (0.8) 0 (0) 0.25
Bronchitis 2 (0.6) 0 (0) 0.5
Sinusitis 2 (0.6) 0 (0) 0.5
Meningitis 2 (0.6) 0 (0) 0.5
Strep pharyngitis 1 (0.3) 1 (0.3) 1
Mastoiditis 0 (0) 0 (0) NA
Urinary tract infection 0 (0) 0 (0) NA
Chicken pox 0 (0) 0 (0) NA
Roseola 0 (0) 0 (0) NA
Taken to a doctor for the illness 45 (12.7) 3 (0.8) ,0.0001a
Treated with antibiotics for the illness 31 (8.7) 2 (0.6) ,0.0001a
Missed school for the illness 23 (6.5) 2 (0.6) ,0.0001a
Associated signs/symptoms
Cough 36 (10.1) 8 (2.3) ,0.0001a
Fever (temperature >101°F or
38.5°C)
33 (9.3) 4 (1.1) ,0.0001a
Runny nose 30 (8.5) 6 (1.7) ,0.0001a
Vomiting 17 (4.8) 0 (0) ,0.0001a
Sore throat 10 (2.8) 5 (1.4) 0.19
Diarrhea 8 (2.3) 0 (0) 0.008a
Ear pain 4 (1.1) 1 (0.3) 0.37
Rash 3 (0.8) 0 (0) 0.25
Ulcers in mouth 1 (0.3) 0 (0) 1
Urinary frequency 1 (0.3) 0 (0) 1
Pain with urination 0 (0) 0 (0) NA
Ulcers on hands/feet 0 (0) 0 (0) NA
Cumulative infections (prior 6 months)
Total infectious illnesses, median
(range)
1 (0–17) 1 (0–6) 0.18
Total days of illness, median (range) 4 (0–180) 3 (0–100) 0.0009a
No. of physician visits for illness,
median (range)
0 (0–14) 0 (0–6) ,0.0001a
Total school/daycare days missed
for illness, median (range)
0 (0–180) 0 (0–40) 0.65
Continued
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Infection could trigger stroke through several dif-
ferent mechanisms.22,23 Infection triggers systemic
inflammation, which activates the coagulation system
and could promote thromboembolism. Varicella-
zoster virus can directly invade the internal carotid
arteries,24 but other infections could have an indirect
pathologic effect on arteries by causing inflammatory
injury to the endothelium. Inflammatory injury to
cardiac endothelium might likewise promote throm-
bus formation in the heart, and secondary cardioem-
bolic stroke. In VIPS, we found that infection was
prevalent across stroke subtypes, arteriopathic and
cardioembolic, suggesting a common mechanism.
Another proposed causal pathway between infection
and arteriopathic stroke is the use of cold remedies
with vasoactive ingredients,25 but little use of such
medications was reported in our study and we found
no association with AIS.
Vaccinations could conceivably reduce risk of AIS
by preventing infection, or transiently increase risk by
causing inflammation. In our analyses, all adjusted for
age, we found only a protective effect of vaccination.
It is possible that vaccinations are simply a marker for
higher SES or better access to care. However, cases
and controls did not differ in reported frequency of
routine visits to a doctor’s office, suggesting equal
access, and the protective effect of vaccination was
independent of SES in our multivariable models.
Because exposures to the different individual vaccines
were highly correlated, we could not determine
whether any one vaccine was particularly (and inde-
pendently) protective against AIS. Rather, we specu-
late that simply being better vaccinated affords some
protection against AIS by decreasing a child’s expo-
sure to infection, and thereby decreasing periods of
transient systemic inflammation.
A number of observational studies have reported
no increased stroke risk after routine vaccination in
adults, and some have even suggested a protective
effect.8,26–29 The only prior pediatric study to assess
vaccination and stroke risk was a retrospective cohort
study that examined the electronic records from 8
medical care organizations, and found no increased
risk of AIS after varicella vaccination.30 However, this
study assessed no other pediatric vaccines, and stroke
diagnoses were based purely on billing codes, which
have ,40% sensitivity for pediatric AIS.1 Our study,
on the other hand, assessed a broad array of pediatric
vaccinations, and used rigorous methods for confirm-
ing the stroke diagnosis. Our findings provide reas-
surance that vaccinations do not increase stroke risk,
and may even reduce risk.
The major limitation of this analysis is the poten-
tial for selection bias, as the controls were biased
against current infections severe enough to require
hospital admission or, in the case of the trauma visit
controls, to decrease activity and thereby reduce risk
of trauma. However, the association with infection re-
mained significant in a sensitivity analysis removing
cases of AIS with major infection, and another analy-
sis comparing cases only to the routine visit controls.
Other limitations are the subjective measure of infec-
tion and ascertainment of vaccination exposure
through parental report, which could have led to
recall bias. However, there was no difference between
cases and controls in parental report of the variables
included as a measure of recall bias, the total number
of infections over the prior 6 months, or exposure to
cold medications. Furthermore, our prior study in the
Kaiser population, although retrospective, had a mea-
sure of infection (documented medical encounter)
resistant to either selection or recall bias, and similarly
demonstrated an association between acute infection
and childhood AIS.15 Other limitations are our inabil-
ity to measure subclinical infections and that our cases
and controls were not matched geographically.
Infection likely acts as a trigger for AIS in children
who are otherwise predisposed to stroke, while rou-
tine childhood vaccinations may be protective. Infec-
tion control through methods like handwashing and
vaccinations may be a strategy for primary stroke
Table 2 Continued
Characteristics
Cases
(n 5 355), n (%)
Controls
(n 5 354), n (%) p Value
Exposure to cold medications
Cold medication taken in prior
24 hours
Vasoactive ingredients
Dextromethorphan 1 (0.3) 0 (0) 1
Pseudoephedrine 1 (0.3) 2 (0.6) 0.62
Phenylpropanolamine 1 (0.3) 0 (0) 1
Ephedra 0 (0) 1 (0.3) 0.5
Not vasoactive
Diphenhydramine 4 (1.1) 0 (0) 0.12
Other cough syrup or cold
preparation
4 (1.1) 1 (0.3) 0.37
Cold medication taken in prior week
Vasoactive ingredients
Dextromethorphan 5 (1.4) 1 (0.3) 0.22
Pseudoephedrine 2 (0.6) 2 (0.6) 1
Phenylpropanolamine 1 (0.3) 0 (0) 1
Ephedra 0 (0.0) 0 (0) NA
Not vasoactive
Diphenhydramine 6 (1.7) 0 (0) 0.03a
Other cough syrup or cold
preparation
9 (2.5) 2 (0.6) 0.06
Abbreviation: NA 5 not applicable.
a Significant.
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prevention. A better understanding of the association
between infection and AIS in children will also
inform the development of strategies for prevention
of recurrent stroke in this important age group.
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Table 3 Exposures to vaccinations among patients with childhood AIS and age-matched controls, measured
by parental interview
Characteristic
Cases (N 5 355),
n/N (%)
Controls (N 5 354),
n/N (%)
Risk of AISa
OR (95% CI) p Value
How many routine vaccines has your
child received?
0.001b
All expected for his or her age 294/355 (82.8) 320/354 (90.4)
Most 21/355 (5.9) 22/354 (6.2)
Some 16/355 (4.5) 2/354 (0.6)
Few 2/355 (0.6) 0/354 (0.0)
None 9/355 (2.5) 2/354 (0.6)
Unknown (missing data) 13/355 (3.7) 8/354 (2.3)
Composite variable for poorly vaccinatedc
(some/few/none)
27/342 (7.9) 4/346 (1.2) 7.3 (2.5–21) 0.0002b
Ever received a routine vaccination againstc
MMR 298/355 (83.9) 327/354 (92.4) 0.40 (0.24–0.68) 0.0007b
Polio 322/341 (94.4) 338/346 (97.7) 0.42 (0.18–0.98) 0.004b
DPT 332/355 (93.5) 344/354 (97.2) 0.43 (0.20–0.93) 0.03b
Pneumococcus 255/324 (78.7) 285/322 (88.5) 0.42 (0.26–0.69) 0.0007b
Varicella 206/325 (63.4) 258/337 (76.6) 0.51 (0.36–0.74) 0.0003b
Meningococcus 211/315 (67.0) 246/323 (76.2) 0.61 (0.42–0.91) 0.01b
Hepatitis A 200/317 (63.1) 214/322 (66.5) 0.88 (0.62–1.25) 0.48
Hepatitis B 266/327 (81.3) 263/340 (77.4) 1.3 (0.96–1.01) 0.17
Any vaccinations, prior 6 months 109/341 (32.0) 123/349 (35.2) 0.82 (0.59–1.15) 0.25
Abbreviations: AIS 5 arterial ischemic stroke; CI 5 confidence interval; DPT 5 diphtheria/pertussis/tetanus; MMR 5 mea-
sles/mumps/rubella; OR 5 odds ratio.
aAdjusted for age and geographic region.
bSignificant.
c Excludes any who answered unknown; all measured vaccines are shown.
Table 4 Multivariate model showing independent
predictors of childhood arterial ischemic
strokea
Characteristics OR (95% CI) p Value
Infection in prior week 6.3 (3.2–12) ,0.0001
Poorly vaccinatedb 8.2 (2.5–26) 0.0004
Residence
Urban Ref
Suburban 2.0 (1.4–2.9) 0.40
Rural 3.0 (1.8–4.8) 0.001
LAMI country 0.84 (0.34–2.1) 0.70
Race
White Ref
Black 2.0 (1.1–3.7) 0.005
Asian 1.0 (0.49–1.8) 0.71
Other/mixed/unknown 0.62 (0.39–0.99) 0.007
Abbreviations: CI 5 confidence interval; LAMI 5 lower and
middle income; OR 5 odds ratio; Ref 5 reference.
aModel also adjusted for sex, season at enrollment, and age
(as a categorical variable because nonlinear).
bComposite variable (some/few/none routine vaccinations).
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